Objective: To investigate the regulating effect of liraglutide therapy on metabolic disorders in patients with newly diagnosed type 2 diabetes complicated with
Objective: To investigate the change of serum inflammatory factors, von Willebrand factor (vWf), vascular endothelial growth factor (VEGF) and adhesion molecule